Regulatory approval

Published by the Health Service Executive. Withdrawn

Treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST).

This is written in the approval document.

Reimbursement

N/A

Citation

Imatinib Therapy - GIST, 2025, version number 4, NCCP National SACT Regimen, NCCP, viewed 02/08/2026, https://healthservice.hse.ie/documents/6727/335_v4_Imatinib.pdf

Therapeutic response

Precision oncology relationships for therapeutic response derived from this regulatory approval.

Organizations	Biomarkers	Cancer types	Therapies

Contributions

Date	Contributor	Description
2024-01-16	Van Allen lab	Adding HSE approvals for reimbursement to database
2016-06-20	Health Service Executive	Indication approved for reimbursement.